Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 43Thyroid Neoplasms 18Thyroid Nodule 7Squamous Cell Carcinoma of Head and Neck 7Mouth Neoplasms 7Lung Neoplasms 6Thyroid Diseases 5Neoplasm Metastasis 5Goiter 5Pain, Postoperative 4Nasopharyngeal Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Renal Cell 4Breast Neoplasms 4Parathyroid Neoplasms 3Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Mucositis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Xerostomia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Thyroid Cancer, Papillary 2Stomatitis 2Stomach Neoplasms 2

Interventions

Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hypoparathyroidism × Head & Neck × Clear all
NCT03969108 2020-03-27

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

University Health Network, Toronto

Phase 4 Completed
10 enrolled
Head & Neck

Goiter, Graves Disease, Hypoparathyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡